Entrepreneurs

What needs to be done in order to bolster downtown and suburban office building leases? How about making sure they are the intelligent office buildings required by modern businesses that compete globally, suggests columnist James Carlini. In this edition of Carlini's Comments, he maintains that...

Virtualization, the process of moving multiple applications running on multiple physical servers to a single virtual server, is gaining traction as it moves from a mere tactical tool to the more strategic role of automating network infrastructure. While long-term savings is a powerful motivator, chief...

A confluence of factors have merged to require CIOs to view themselves not as technology leaders but business leaders. The opportunities to do so, which include having an impact when the economy is showing signs of slowing down, was a major theme of Gartner Symposium/ITxpo...

Globalization briskly marches on - one step ahead of our ability to measure and understand its effects. Economists, corporate leaders, and government officials trumpet the benefits of globalization but few have called attention to the risks for countries, companies, and individuals, opines Tony DiRomualdo. ...

Global companies are discovering Wisconsin's many business benefits, as Microsoft's recent acquisition of Jellyfish.com clearly demonstrates, according to Inside Wisconsin columnist Tom Still. Microsoft, however, is only the latest corporate giant to "Discover Wisconsin" and its business merits, which speaks volumes about Wisconsin's ability...

WiMAX will be a big alternative to big cities, especially after the “free” Wi-Fi business model has fizzled, observes James Carlini, and that's one of several impressions from the recent WiMAX WORLD Conference in Chicago. In this edition of Carlini's Comments, he said the conference...

Cellectar, which designs and develops products to detect, treat, and monitor human cancers, has named Ernest Allen as director of clinical operations and Lisa Ann Trembath as manager of medical affairs. The appointments come as Cellectar moves its lead drug candidate toward clinical trials....

TomoTherapy executives prefer investors to take the long view of their financial performance, but the company's projected third quarter performance is nothing to scoff at. The Madison based medical device manufacturer has revised its third quarter projections, which indicate a 61 percent increase in anticipated...